Related Experiment Videos
Radioimmunoassay for desmethylimipramine.
Psychopharmacology Communications
|January 11, 1975
Summary
Researchers developed a new radioimmunoassay to detect demethyl-imipramine (DMI) in biological samples. This sensitive assay can measure DMI in small amounts of rat plasma and brain tissue.
Area of Science:
- Pharmacology
- Immunology
- Analytical Chemistry
Background:
- Demethyl-imipramine (DMI) is a tricyclic antidepressant.
- Accurate quantification of DMI is crucial for pharmacokinetic and pharmacodynamic studies.
- Existing methods may require larger sample volumes.
Purpose of the Study:
- To develop and validate a sensitive radioimmunoassay for demethyl-imipramine (DMI).
- To enable the measurement of DMI in limited biological sample volumes.
Main Methods:
- Production of specific antibodies against demethyl-imipramine (DMI).
- Development of a radioimmunoassay (RIA) using the generated antisera.
- Validation of the RIA for sensitivity and linearity.
Main Results:
- Successfully produced antibodies against DMI.
- Developed a radioimmunoassay capable of detecting 0.2 ng of DMI.
- The assay demonstrated linearity up to 25 ng.
- Applied the assay to measure DMI in rat plasma and brain samples.
Conclusions:
- A sensitive and specific radioimmunoassay for DMI has been established.
- This assay is suitable for measuring DMI in small quantities of biological matrices.
- The method offers a valuable tool for research involving limited sample availability.